Author

Michael M. Allevato

Moores Cancer Center, University of California San Diego, La Jolla, California. 1ORCID 0000-0003-1846-7189Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Jorge Silvio GutkindiD· 2 shared Ayush KishoreiD· 1 shared Bamdad Zareh· 1 shared Dina V. HingoraniiD· 1 shared Hiroki IzumiiD· 1 shared Jacqueline Lesperance· 1 shared Kanika DhawaniD· 1 shared Keiichi KoshizukaiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Jorge Silvio GutkindORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyCancer LettersPeer-reviewedJun 20, 2026

Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses

Kanika Dhawan, Michael M. Allevato, Jacqueline Lesperance…·Sunil J. Advani

This paper develops a targeted radiosensitizer drug conjugate that enhances tumor control and immune responses while minimizing toxicity to normal tissues.

DOI 10.1016/j.canlet.2026.218689

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivAug 7, 2023

A kinome-wide synthetic lethal CRISPR/Cas9 screen reveals that mTOR inhibition prevents adaptive resistance to CDK4/CDK6 blockade in HNSCC

Yusuke Goto, Keiichi Koshizuka, Toshinori Ando…·J. Silvio Gutkind

This study identifies mTOR inhibition as a way to prevent adaptive resistance to CDK4/6 blockade in HNSCC by targeting cell cycle pathways.

DOI 10.1158/2767-9764.crc-24-0247

humanexperimental assay

𝕏 PostBluesky